Stress Induced Hyperglycemia In Trauma

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02999386
• Date of registration: 15/12/2016
• Prospective Registration: No
• Primary sponsor: Hamad Medical Corporation
• Public title: Stress Induced Hyperglycemia In Trauma SIHG
• Scientific title: Role Of Stress Induced Hyperglycemia On The Outcome Of Trauma Patients
• Date of first enrolment: October 2016
• Target sample size: 300
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02999386
• Study type: Observational

Countries of recruitment

Qatar

Contacts

• Name: Ayman El-Menyar, MD
• Affiliation: Hamad Medical Coorporation

Key inclusion & exclusion criteria

Inclusion Criteria:

- All adult (=18 years) male and female trauma patients consented for participation and
have been investigated for random plasma glucose level and HbA1C measured within 5
hours of hospital admission will be included in the study.

Exclusion Criteria:

- Patients who descend to participate or in whom random serum glucose level and HbA1C
not measured within 5 hours of hospital admission will be excluded from the study.

- Also, vulnerable populations (children, and pregnant women), and alcoholics will be
excluded from the study.



Age minimum: 18 Years
Age maximum: 80 Years
Gender: All

Health Condition(s) or Problem(s) studied

Diabetes Mellitus

Stress Induced Hyperglycemia

Trauma

Primary Outcome(s)

All cause Mortality [Time Frame: 30 days]

Secondary Outcome(s)

Hospital length of stay [Time Frame: 1 year]

Multiorgan failure [Time Frame: 30 days]

Pneumonia [Time Frame: 30 days]

Sepsis [Time Frame: 30 days]

Secondary ID(s)

14471/14

Source(s) of Monetary Support

Please refer to primary and secondary sponsors